IRONWOOD PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$265.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-18.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2022-02-18
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-12-31 was -$28.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-09-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-06-30 was -$376.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-03-31 was -$1.44M, a 215.41% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2021 was -$265.00K.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2020 was -$1.84M.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2019 was -$6.92M, a 107.13% decline from fiscal 2018.
- IRONWOOD PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was $97.14M, a 36.46% decline from fiscal 2017.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$265.00K 10-K · filed 2022-02-18 | |||
| 2020-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$28.00K derived: sum of 2 quarters · filed 2022-02-18 | -$404.00K derived: sum of 3 quarters · filed 2022-02-18 | -$1.84M 10-K · filed 2022-02-18 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$376.00K derived: sum of 2 quarters · filed 2020-11-05 | -$1.81M 10-Q · filed 2020-11-05 | -$4.47M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | -$376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.81M 10-Q · filed 2020-08-06 | -$4.47M derived: sum of 3 quarters · filed 2022-02-18 | -$7.55M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | -$1.44M 10-Q · filed 2020-05-06 | -$4.10M derived: sum of 2 quarters · filed 2022-02-18 | -$7.18M derived: sum of 3 quarters · filed 2022-02-18 | -$9.61M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | -$2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$5.74M derived: sum of 2 quarters · filed 2022-02-18 | -$8.17M derived: sum of 3 quarters · filed 2022-02-18 | -$6.92M 10-K · filed 2022-02-18 |
| 2019-09-30 | -$3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$5.51M derived: sum of 2 quarters · filed 2020-11-05 | -$4.26M 10-Q · filed 2020-11-05 | $16.27M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | -$2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.18M 10-Q · filed 2020-08-06 | $19.35M derived: sum of 3 quarters · filed 2021-02-17 | $37.11M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $1.25M 10-Q · filed 2020-05-06 | $21.78M derived: sum of 2 quarters · filed 2021-02-17 | $39.53M derived: sum of 3 quarters · filed 2021-02-17 | |
| 2018-12-31 | $20.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $38.29M derived: sum of 2 quarters · filed 2021-02-17 | $97.14M 10-K · filed 2021-02-17 | |
| 2018-09-30 | $17.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $76.60M 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $58.85M 10-Q · filed 2019-07-30 | |||
| 2017-12-31 | $152.87M 10-K · filed 2020-02-13 | |||
| 2017-03-31 | $88.06M 10-Q · filed 2017-05-08 | |||
| 2016-09-30 | -$90.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$85.60M derived: sum of 2 quarters · filed 2016-11-07 | -$62.25M 10-Q · filed 2016-11-07 | -$27.34M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-06-30 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $28.11M 10-Q · filed 2016-08-08 | $63.02M derived: sum of 3 quarters · filed 2017-05-08 | $84.86M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-03-31 | $23.35M 10-Q · filed 2017-05-08 | $58.26M derived: sum of 2 quarters · filed 2017-05-08 | $80.09M derived: sum of 3 quarters · filed 2017-05-08 | -$5.57M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $34.91M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $56.74M derived: sum of 2 quarters · filed 2016-11-07 | -$28.91M derived: sum of 3 quarters · filed 2016-11-07 | -$9.15M 10-K · filed 2016-02-19 |
| 2015-09-30 | $21.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$63.83M derived: sum of 2 quarters · filed 2016-11-07 | -$44.07M 10-Q · filed 2016-11-07 | -$5.75M derived: sum of 4 quarters · filed 2016-11-07 |
| 2015-06-30 | -$85.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$65.90M 10-Q · filed 2016-08-08 | -$27.59M derived: sum of 3 quarters · filed 2016-08-08 | -$35.47M derived: sum of 4 quarters · filed 2016-08-08 |
| 2015-03-31 | $19.76M 10-Q · filed 2016-05-10 | $58.07M derived: sum of 2 quarters · filed 2016-05-10 | $50.19M derived: sum of 3 quarters · filed 2016-05-10 | |
| 2014-12-31 | $38.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $30.43M derived: sum of 2 quarters · filed 2016-02-19 | -$56.57M 10-K · filed 2016-02-19 | |
| 2014-09-30 | -$7.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$94.88M 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$87.00M 10-Q · filed 2015-08-07 | |||
| 2013-12-31 | -$101.43M 10-K · filed 2016-02-19 | |||
| 2012-12-31 | $32.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $31.55M derived: sum of 2 quarters · filed 2013-02-21 | $28.79M derived: sum of 3 quarters · filed 2013-02-21 | $30.08M 10-K · filed 2013-02-21 |
| 2012-09-30 | -$680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$3.44M derived: sum of 2 quarters · filed 2012-11-06 | -$2.15M 10-Q · filed 2012-11-06 | $23.40M derived: sum of 4 quarters · filed 2013-02-21 |
| 2012-06-30 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$1.47M 10-Q · filed 2012-08-07 | $24.08M derived: sum of 3 quarters · filed 2013-02-21 | $69.56M derived: sum of 4 quarters · filed 2013-02-21 |
| 2012-03-31 | $1.29M 10-Q · filed 2012-05-10 | $26.83M derived: sum of 2 quarters · filed 2013-02-21 | $72.32M derived: sum of 3 quarters · filed 2013-02-21 | $91.15M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-12-31 | $25.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $71.03M derived: sum of 2 quarters · filed 2013-02-21 | $89.86M derived: sum of 3 quarters · filed 2013-02-21 | $115.06M 10-K · filed 2013-02-21 |
| 2011-09-30 | $45.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $64.31M derived: sum of 2 quarters · filed 2012-11-06 | $89.52M 10-Q · filed 2012-11-06 | $75.05M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $18.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $44.04M 10-Q · filed 2012-08-07 | $29.57M derived: sum of 3 quarters · filed 2013-02-21 | $76.26M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $25.21M 10-Q · filed 2012-05-10 | $10.74M derived: sum of 2 quarters · filed 2013-02-21 | $57.43M derived: sum of 3 quarters · filed 2013-02-21 | |
| 2010-12-31 | -$14.47M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $32.23M derived: sum of 2 quarters · filed 2013-02-21 | -$213.04M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $46.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$198.57M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$245.27M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $18.28M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |